Question 1

What is Xtampza ER?

Accepted Answer

Xtampza ER is an extended-release opioid agonist that contains oxycodone as its active component. This medication is formulated to provide a consistent delivery of its active ingredient over an extended period, distinguishing it from immediate-release versions of the same drug.

It is classified as a narcotic analgesic. The formulation is designed to maintain stable levels of the medication in the body by acting on the central nervous system.

Question 2

What is Xtampza ER used for?

Accepted Answer

Xtampza ER is used to treat pain requiring long-term opioid treatment.

Question 3

How does Xtampza ER work?

Accepted Answer

Mechanism of Action

Xtampza ER contains oxycodone, a type of medicine known as an opioid agonist. It works by attaching to specific proteins called opioid receptors located in the brain, spinal cord, and other parts of the body. When the medicine binds to these receptors, it blocks pain signals and changes the way the body perceives and reacts to pain.

Extended-Release Delivery

This medication is designed for around-the-clock treatment of severe pain that cannot be managed by other treatments. Unlike immediate-release medications that work quickly and then wear off, Xtampza ER is formulated to release oxycodone gradually over approximately 12 hours. This slow release helps maintain a steady level of the drug in the bloodstream.

Formulation Design

The active ingredient in Xtampza ER is contained within many tiny microspheres. This specific formulation is intended to ensure that the medication continues to release slowly even if the capsule is opened and the contents are sprinkled onto soft food. This design helps prevent the sudden release of a large amount of medication at once.

Question 4

What are the active ingredients in Xtampza ER?

Accepted Answer

The active ingredient in Xtampza ER is Oxycodone .

Question 5

What are the side effects of Xtampza ER?

Accepted Answer

Common side effects of Xtampza ER may include:

Constipation

Nausea

Drowsiness

Others

Always consult with a healthcare professional about potential side effects.

Question 6

What drug class is Xtampza ER?

Accepted Answer

Xtampza ER belongs to the opioid analgesic drug class.

Question 7

What is the dosage of Xtampza ER and how do I take it?

Accepted Answer

How to Take

Xtampza ER should be taken exactly as directed by a healthcare provider. It is typically taken twice daily, approximately every 12 hours. It is essential to take each dose with approximately the same amount of food to ensure the medication is absorbed consistently by the body.

Administration Methods

Swallowing whole: The capsules should be swallowed whole with enough water to ensure they are completely swallowed.

Sprinkling on food: If you have difficulty swallowing, the capsule may be opened and the contents sprinkled onto soft foods such as applesauce, pudding, or yogurt. The mixture should be consumed immediately without chewing the beads.

Feeding tubes: The contents of the capsule can also be administered through certain types of feeding tubes as directed by a healthcare professional.

Do not crush, chew, or dissolve the contents of the capsule, as this can interfere with the extended-release mechanism.

Missed Dose

If a dose is missed, it should be taken as soon as it is remembered. However, if it is almost time for the next scheduled dose, the missed dose should be skipped. Do not take two doses at once to make up for a missed one.

Question 8

Is Xtampza ER safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

Prolonged use of opioid medications like Xtampza ER during pregnancy can result in neonatal opioid withdrawal syndrome (NOWS). This condition occurs because the fetus can become physically dependent on the drug. After birth, the infant may require specialized medical treatment for withdrawal symptoms, which can be life-threatening if not managed correctly.

Symptoms of neonatal withdrawal may include:

Irritability and excessive or high-pitched crying

Tremors or seizures

Difficulty feeding or vomiting

Diarrhea and failure to gain weight

Using this medication near the time of delivery may also cause respiratory depression in the newborn, leading to slowed or shallow breathing. Medical professionals should be prepared to provide resuscitation or use reversal agents if needed.

Breastfeeding

The active ingredient in Xtampza ER, oxycodone, is excreted in human breast milk. This can lead to serious side effects in a nursing infant, such as extreme sleepiness, limpness, or breathing difficulties. If a person suddenly stops taking the medication while breastfeeding, the infant may also experience withdrawal symptoms.

Due to these risks, it is important to monitor breastfed infants for any unusual signs of sedation. Patients should discuss their options with a healthcare provider to determine the safest approach for both the parent and the child.

Question 9

What forms and strengths does Xtampza ER come in?

Accepted Answer

Xtampza ER is supplied as an oral extended-release capsule. The medication is formulated within microspheres inside the capsule to allow for a steady release over time.

Administration Methods

Swallowing whole: The capsules are typically swallowed whole with enough water to ensure complete swallowing.

Sprinkling on food: For patients who have difficulty swallowing, the capsules can be opened and the contents sprinkled onto soft foods such as applesauce, pudding, or yogurt.

Feeding tubes: The contents of the opened capsules may also be administered through gastric or nasogastric feeding tubes.

Question 10

What is the FDA approval status of Xtampza ER?

Accepted Answer

FDA Approval and Indication: Xtampza ER was approved by the U.S. Food and Drug Administration (FDA) in 2016. It is indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment for which alternative treatment options are inadequate. It is not intended for use as an as-needed analgesic.

Controlled Substance Status: The FDA classifies Xtampza ER as a Schedule II controlled substance. This classification indicates that the medication has a high potential for abuse, which may lead to severe psychological or physical dependence.

Boxed Warning and Safety Requirements: Xtampza ER carries a boxed warning, the FDA’s most serious warning, highlighting several critical risks:

Addiction, Abuse, and Misuse: Use of this medication exposes users to the risks of opioid addiction and misuse, which can lead to overdose and death.

Respiratory Depression: Serious, life-threatening, or fatal breathing problems may occur.

Accidental Ingestion: Accidental ingestion of even one dose, especially by children, can result in a fatal overdose.

Neonatal Opioid Withdrawal Syndrome: Prolonged use during pregnancy can result in life-threatening withdrawal symptoms in the newborn.

Interactions with Other Depressants: Using opioids with benzodiazepines or other central nervous system depressants can cause profound sedation, respiratory depression, coma, and death.

REMS Program: To ensure the benefits of the medication outweigh the risks of misuse and abuse, Xtampza ER is part of the Opioid Analgesic Risk Evaluation and Mitigation Strategy (REMS). This program requires that healthcare providers are made aware of the risks and that patients receive education on the safe use of these products.

Abuse-Deterrent Labeling: The FDA has approved labeling for Xtampza ER that describes its abuse-deterrent properties. The medication is formulated to maintain its extended-release profile even if the capsules are crushed or chewed, which is intended to discourage common methods of manipulation for abuse, such as snorting or injection.

Question 11

What should I know about Xtampza ER and withdrawal?

Accepted Answer

Withdrawal Risks

Physical dependence is a common occurrence with long-term use of Xtampza ER. If the medication is stopped suddenly or the dose is lowered too quickly, withdrawal symptoms may develop.

Common Withdrawal Symptoms

Symptoms of opioid withdrawal can include:

Restlessness, anxiety, and irritability

Muscle aches, backache, or joint pain

Stomach cramps, nausea, vomiting, or diarrhea

Insomnia or difficulty sleeping

Increased heart rate, blood pressure, or respiratory rate

Sweating, chills, or goose bumps

Runny nose, watery eyes, or frequent yawning

Dilated pupils and loss of appetite

Safe Tapering

To minimize the risk of withdrawal, healthcare providers typically recommend a gradual reduction in dosage rather than stopping the medication all at once. This process, known as tapering, allows the body to adjust slowly. The specific schedule for tapering depends on the individual's medical history and the duration of treatment.

Xtampza ER

Medication Quick Facts

📋Overview

What It's Used For

How It Works

Side Effects

Warnings & Precautions

Dosage & How to Take

Pregnancy & Breastfeeding

Forms & Strengths

FDA / Regulatory Status

Withdrawal Information

FAQ

Found an Error?